ACS Publications. Most Trusted. Most Cited. Most Read
Design and Selection Parameters to Accelerate the Discovery of Novel Central Nervous System Positron Emission Tomography (PET) Ligands and Their Application in the Development of a Novel Phosphodiesterase 2A PET Ligand
My Activity
    Article

    Design and Selection Parameters to Accelerate the Discovery of Novel Central Nervous System Positron Emission Tomography (PET) Ligands and Their Application in the Development of a Novel Phosphodiesterase 2A PET Ligand
    Click to copy article linkArticle link copied!

    View Author Information
    Neuroscience Medicinal Chemistry, Pfizer Inc., Cambridge, Massachusetts 02139, United States
    Neuroscience Medicinal Chemistry, Pfizer Inc., Groton, Connecticut 06340, United States
    § BioImaging Center, Precision Medicine, Pfizer Inc., Groton, Connecticut 06340, United States
    Neuroscience Research Unit, Pfizer Inc., Cambridge, Massachusetts 02139, United States
    Data Analytical Group, Groton Center of Chemistry, Groton, Connecticut 06340, United States
    *Phone: +1 617 395 0640. Fax: +1 860 686 5285. E-mail: [email protected]
    Other Access OptionsSupporting Information (2)

    Journal of Medicinal Chemistry

    Cite this: J. Med. Chem. 2013, 56, 11, 4568–4579
    Click to copy citationCitation copied!
    https://doi.org/10.1021/jm400312y
    Published May 7, 2013
    Copyright © 2013 American Chemical Society

    Abstract

    Click to copy section linkSection link copied!
    Abstract Image

    To accelerate the discovery of novel small molecule central nervous system (CNS) positron emission tomography (PET) ligands, we aimed to define a property space that would facilitate ligand design and prioritization, thereby providing a higher probability of success for novel PET ligand development. Toward this end, we built a database consisting of 62 PET ligands that have successfully reached the clinic and 15 radioligands that failed in late-stage development as negative controls. A systematic analysis of these ligands identified a set of preferred parameters for physicochemical properties, brain permeability, and nonspecific binding (NSB). These preferred parameters have subsequently been applied to several programs and have led to the successful development of novel PET ligands with reduced resources and timelines. This strategy is illustrated here by the discovery of the novel phosphodiesterase 2A (PDE2A) PET ligand 4-(3-[18F]fluoroazetidin-1-yl)-7-methyl-5-{1-methyl-5-[4-(trifluoromethyl)phenyl]-1H-pyrazol-4-yl}imidazo[5,1-f][1,2,4]triazine, [18F]PF-05270430 (5).

    Copyright © 2013 American Chemical Society

    Read this article

    To access this article, please review the available access options below.

    Get instant access

    Purchase Access

    Read this article for 48 hours. Check out below using your ACS ID or as a guest.

    Recommended

    Access through Your Institution

    You may have access to this article through your institution.

    Your institution does not have access to this content. Add or change your institution or let them know you’d like them to include access.

    Supporting Information

    Click to copy section linkSection link copied!

    The full data set of the PET ligand database, an extended version of Table 2 with individual parameters of CNS PET MPO (ClogP, ClogD, MW, HBD, TPSA, and pKa), and a CNS PET MPO calculator in Excel format. This material is available free of charge via the Internet at http://pubs.acs.org.

    Terms & Conditions

    Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: http://pubs.acs.org/page/copyright/permissions.html.

    Cited By

    Click to copy section linkSection link copied!
    Citation Statements
    Explore this article's citation statements on scite.ai

    This article is cited by 174 publications.

    1. Clemens P. Spielvogel, Natalie Schindler, Christian Schröder, Sarah Luise Stellnberger, Wolfgang Wadsak, Markus Mitterhauser, Laszlo Papp, Marcus Hacker, Verena Pichler, Chrysoula Vraka. Enhancing Blood–Brain Barrier Penetration Prediction by Machine Learning-Based Integration of Novel and Existing, In Silico and Experimental Molecular Parameters from a Standardized Database. Journal of Chemical Information and Modeling 2025, 65 (6) , 2773-2784. https://doi.org/10.1021/acs.jcim.4c02212
    2. Jeffrey S. Stehouwer, Guofeng Huang, Dinahlee Saturnino Guarino, Manik L. Debnath, Ashok Polu, Steven J. Geib, Brian Lopresti, Milos D. Ikonomovic, Neale Mason, Robert H. Mach, Chester A. Mathis. Structure–Activity Relationships and Evaluation of 2-(Heteroaryl-cycloalkyl)-1H-indoles as Tauopathy Positron Emission Tomography Radiotracers. Journal of Medicinal Chemistry 2025, Article ASAP.
    3. Sridhar Goud Nerella, Mark A. G. Eldridge, Robert B. Innis, Victor W. Pike. PET Reporter Probes for Brain Imaging of Transduced Gene and Cell Expression: Status and Challenges. Journal of Medicinal Chemistry 2025, 68 (3) , 2198-2218. https://doi.org/10.1021/acs.jmedchem.4c02326
    4. Yui Ishizaka, Hiroyuki Watanabe, Masahiro Ono. Structure-Affinity-Pharmacokinetics Relationships of Novel 18F-Labeled 1,4-Diazepane Derivatives for Orexin 1 Receptor Imaging. Journal of Medicinal Chemistry 2024, 67 (21) , 18781-18793. https://doi.org/10.1021/acs.jmedchem.4c01090
    5. Meijuan Jiang, Nicholas R. Ellin, Sanjay Telu, Maulik Mungalpara, Xuedan Wu, Zibo Li, Shuiyu Lu, Victor W. Pike. Difluoromethoxide Is a Strong Leaving Group in the Photoredox Deoxyradiofluorination of 2-Phenylpyridines. The Journal of Organic Chemistry 2024, 89 (18) , 13768-13773. https://doi.org/10.1021/acs.joc.4c01505
    6. Zhen Chen, Jiahui Chen, Wakana Mori, Yongjia Yi, Jian Rong, Yinlong Li, Erick R. Calderon Leon, Tuo Shao, Zhendong Song, Tomoteru Yamasaki, Hideki Ishii, Yiding Zhang, Tomomi Kokufuta, Kuan Hu, Lin Xie, Lee Josephson, Richard Van, Yihan Shao, Stewart Factor, Ming-Rong Zhang, Steven H. Liang. Preclinical Evaluation of Novel Positron Emission Tomography (PET) Probes for Imaging Leucine-Rich Repeat Kinase 2 (LRRK2). Journal of Medicinal Chemistry 2024, 67 (4) , 2559-2569. https://doi.org/10.1021/acs.jmedchem.3c01687
    7. E. Johanna L. Stéen, A Yeong Park, Wissam Beaino, Changdev Gorakshnath Gadhe, Esther Kooijman, Robert C. Schuit, Maxime Schreurs, Prisca Leferink, Jeroen J. M. Hoozemans, Jae Eun Kim, Jinhwa Lee, Albert D. Windhorst. Development of 18F-Labeled PET Tracer Candidates for Imaging of the Abelson Non-receptor Tyrosine Kinase in Parkinson’s Disease. Journal of Medicinal Chemistry 2023, 66 (18) , 12990-13006. https://doi.org/10.1021/acs.jmedchem.3c00902
    8. James J. Perkins, Paul McQuade, Christopher J. Bungard, Tracy L. Diamond, Liza T. Gantert, Anthony L. Gotter, Barbara Hanney, Ivory D. Hills, Danielle M. Hurzy, Aniket Joshi, Jonathan T. Kern, Kelly-Ann S. Schlegel, Jesse J. Manikowski, Zhaoyang Meng, Julie A. O’Brien, Anthony J. Roecker, Sean M. Smith, Jason M. Uslaner, Eric Hostetler, Robert S. Meissner. Discovery of [11C]MK-8056: A Selective PET Imaging Agent for the Study of mGluR2 Negative Allosteric Modulators. ACS Medicinal Chemistry Letters 2023, 14 (7) , 986-992. https://doi.org/10.1021/acsmedchemlett.3c00175
    9. Melissa Chassé, Neil Vasdev. Synthesis and Preclinical Positron Emission Tomography Imaging of the p38 MAPK Inhibitor [11C]Talmapimod: Effects of Drug Efflux and Sex Differences. ACS Chemical Neuroscience 2023, 14 (11) , 2193-2200. https://doi.org/10.1021/acschemneuro.3c00205
    10. Zhen Chen, Jiahui Chen, Laigao Chen, Chi-Hyeon Yoo, Jian Rong, Hualong Fu, Tuo Shao, Karen Coffman, Stefanus J. Steyn, April T. Davenport, James B. Daunais, Achi Haider, Lee Collier, Lee Josephson, Hsiao-Ying Wey, Lei Zhang, Steven H. Liang. Imaging Leucine-Rich Repeat Kinase 2 In Vivo with 18F-Labeled Positron Emission Tomography Ligand. Journal of Medicinal Chemistry 2023, 66 (3) , 1712-1724. https://doi.org/10.1021/acs.jmedchem.2c00551
    11. Meijuan Jiang, Shuiyu Lu, Sanjay Telu, Victor W. Pike. An Empirical Quantitative Structure-Activity Relationship Equation Assists the Discovery of High-Affinity Phosphodiesterase 4D Inhibitors as Leads to PET Radioligands. Journal of Medicinal Chemistry 2023, 66 (2) , 1543-1561. https://doi.org/10.1021/acs.jmedchem.2c01745
    12. Longbin Liu, Peter D. Johnson, Michael E. Prime, Vinod Khetarpal, Christopher J. Brown, Luca Anzillotti, Daniele Bertoglio, Xuemei Chen, Samuel Coe, Randall Davis, Anthony P. Dickie, Simone Esposito, Elise Gadouleau, Paul R. Giles, Catherine Greenaway, James Haber, Christer Halldin, Scott Haller, Sarah Hayes, Todd Herbst, Frank Herrmann, Manuela Heßmann, Ming Min Hsai, Yaser Khani, Adrian Kotey, Angelo Lembo, John E. Mangette, Gwendolyn A. Marriner, Richard W. Marston, Matthew R. Mills, Edith Monteagudo, Anton Forsberg-Morén, Sangram Nag, Laura Orsatti, Christine Sandiego, Sabine Schaertl, Joanne Sproston, Steven Staelens, Jack Tookey, Penelope A. Turner, Andrea Vecchi, Maria Veneziano, Ignacio Muñoz-Sanjuan, Jonathan Bard, Celia Dominguez. Design and Evaluation of [18F]CHDI-650 as a Positron Emission Tomography Ligand to Image Mutant Huntingtin Aggregates. Journal of Medicinal Chemistry 2023, 66 (1) , 641-656. https://doi.org/10.1021/acs.jmedchem.2c01585
    13. Erin L. ColeLindsey R. Drake. POSITRON EMISSION TOMOGRAPHY NEUROIMAGING IN DRUG DISCOVERY AND DEVELOPMENT. , 61-90. https://doi.org/10.1021/mc-2022-vol57.ch03
    14. Sho Kaide, Hiroyuki Watanabe, Shimpei Iikuni, Masato Hasegawa, Masahiro Ono. Synthesis and Evaluation of 18F-Labeled Chalcone Analogue for Detection of α-Synuclein Aggregates in the Brain Using the Mouse Model. ACS Chemical Neuroscience 2022, 13 (20) , 2982-2990. https://doi.org/10.1021/acschemneuro.2c00473
    15. Kohei Nakagawa, Hiroyuki Watanabe, Sho Kaide, Masahiro Ono. Structure–Activity Relationships of Styrylquinoline and Styrylquinoxaline Derivatives as α-Synuclein Imaging Probes. ACS Medicinal Chemistry Letters 2022, 13 (10) , 1598-1605. https://doi.org/10.1021/acsmedchemlett.2c00279
    16. Mari Nakaie, Fumihiro Katayama, Takehiro Nakagaki, Sakura Yoshida, Masao Kawasaki, Kodai Nishi, Kazuma Ogawa, Akira Toriba, Noriyuki Nishida, Morio Nakayama, Takeshi Fuchigami. Synthesis and Biological Evaluation of Novel 2-(Benzofuran-2-yl)-chromone Derivatives for In Vivo Imaging of Prion Deposits in the Brain. ACS Infectious Diseases 2022, 8 (9) , 1869-1882. https://doi.org/10.1021/acsinfecdis.2c00142
    17. Hualong Fu, Jian Rong, Zhen Chen, Jingyin Zhou, Thomas Collier, Steven H. Liang. Positron Emission Tomography (PET) Imaging Tracers for Serotonin Receptors. Journal of Medicinal Chemistry 2022, 65 (16) , 10755-10808. https://doi.org/10.1021/acs.jmedchem.2c00633
    18. Isaac M. Jackson, E. William Webb, Peter J.H. Scott, Michelle L. James. In Silico Approaches for Addressing Challenges in CNS Radiopharmaceutical Design. ACS Chemical Neuroscience 2022, 13 (12) , 1675-1683. https://doi.org/10.1021/acschemneuro.2c00269
    19. Arindam Talukdar, Ayan Mukherjee, Debomita Bhattacharya. Fascinating Transformation of SAM-Competitive Protein Methyltransferase Inhibitors from Nucleoside Analogues to Non-Nucleoside Analogues. Journal of Medicinal Chemistry 2022, 65 (3) , 1662-1684. https://doi.org/10.1021/acs.jmedchem.1c01208
    20. Yingfang He, Matthias Schild, Uwe Grether, Jörg Benz, Lea Leibrock, Dominik Heer, Andreas Topp, Ludovic Collin, Bernd Kuhn, Matthias Wittwer, Claudia Keller, Luca C. Gobbi, Roger Schibli, Linjing Mu. Development of High Brain-Penetrant and Reversible Monoacylglycerol Lipase PET Tracers for Neuroimaging. Journal of Medicinal Chemistry 2022, 65 (3) , 2191-2207. https://doi.org/10.1021/acs.jmedchem.1c01706
    21. Berend van der Wildt, Bieneke Janssen, Aleksandra Pekošak, E. Johanna L. Stéen, Robert C. Schuit, Esther J. M. Kooijman, Wissam Beaino, Danielle J. Vugts, Albert D. Windhorst. Novel Thienopyrimidine-Based PET Tracers for P2Y12 Receptor Imaging in the Brain. ACS Chemical Neuroscience 2021, 12 (23) , 4465-4474. https://doi.org/10.1021/acschemneuro.1c00641
    22. Mariateresa Giustiniano, Christian W. Gruber, Caitlin N. Kent, Paul C. Trippier. Back to the Medicinal Chemistry Future. Journal of Medicinal Chemistry 2021, 64 (21) , 15515-15518. https://doi.org/10.1021/acs.jmedchem.1c01788
    23. Chris Hoffmann, Sibel Evcüman, Felix Neumaier, Boris D. Zlatopolskiy, Swen Humpert, Dirk Bier, Marcus Holschbach, Annette Schulze, Heike Endepols, Bernd Neumaier. [18F]ALX5406: A Brain-Penetrating Prodrug for GlyT1-Specific PET Imaging. ACS Chemical Neuroscience 2021, 12 (18) , 3335-3346. https://doi.org/10.1021/acschemneuro.1c00284
    24. Longbin Liu, Peter D. Johnson, Michael E. Prime, Vinod Khetarpal, Matthew R. Lee, Christopher J. Brown, Xuemei Chen, Daniel Clark-Frew, Samuel Coe, Mike Conlon, Randall Davis, Samantha Ensor, Simone Esposito, Anton Forsberg Moren, Xinjie Gai, Samantha Green, Catherine Greenaway, James Haber, Christer Halldin, Sarah Hayes, Todd Herbst, Frank Herrmann, Manuela Heßmann, Ming Min Hsai, Adrian Kotey, John E. Mangette, Matthew R. Mills, Edith Monteagudo, Sangram Nag, Martina Nibbio, Laura Orsatti, Sabine Schaertl, Christoph Scheich, Joanne Sproston, Vladimir Stepanov, Katarina Varnäs, Andrea Varrone, John Wityak, Ladislav Mrzljak, Ignacio Munoz-Sanjuan, Jonathan A. Bard, Celia Dominguez. [11C]CHDI-626, a PET Tracer Candidate for Imaging Mutant Huntingtin Aggregates with Reduced Binding to AD Pathological Proteins. Journal of Medicinal Chemistry 2021, 64 (16) , 12003-12021. https://doi.org/10.1021/acs.jmedchem.1c00667
    25. Jiyun Sun, Zhiwei Xiao, Achi Haider, Catherine Gebhard, Hao Xu, Hai-Bin Luo, Han-Ting Zhang, Lee Josephson, Lu Wang, Steven H. Liang. Advances in Cyclic Nucleotide Phosphodiesterase-Targeted PET Imaging and Drug Discovery. Journal of Medicinal Chemistry 2021, 64 (11) , 7083-7109. https://doi.org/10.1021/acs.jmedchem.1c00115
    26. Yuta Takamura, Hiroki Kakuta. In Vivo Receptor Visualization and Evaluation of Receptor Occupancy with Positron Emission Tomography. Journal of Medicinal Chemistry 2021, 64 (9) , 5226-5251. https://doi.org/10.1021/acs.jmedchem.0c01714
    27. Yasushi Hattori, Satoru Matsuda, Rina Baba, Kouta Matsumiya, Shinji Iwasaki, Cristian C. Constantinescu, Thomas J. Morley, Vincent M. Carroll, Caroline Papin, Alexandra Gouasmat, David Alagille, Gilles Tamagnan, Tatsuki Koike. Design, Synthesis, and Evaluation of (2-Aminocyclopropyl)phenyl Derivatives as Novel Positron Emission Tomography Imaging Agents for Lysine-Specific Demethylase 1 in the Brain. Journal of Medicinal Chemistry 2021, 64 (7) , 3780-3793. https://doi.org/10.1021/acs.jmedchem.0c01937
    28. Longbin Liu, Michael E. Prime, Matt R. Lee, Vinod Khetarpal, Christopher J. Brown, Peter D. Johnson, Patricia Miranda-Azpiazu, Xuemei Chen, Daniel Clark-Frew, Samuel Coe, Randall Davis, Anthony Dickie, Andreas Ebneth, Simone Esposito, Elise Gadouleau, Xinjie Gai, Sebastien Galan, Samantha Green, Catherine Greenaway, Paul Giles, Christer Halldin, Sarah Hayes, Todd Herbst, Frank Herrmann, Manuela Heßmann, Zhisheng Jia, Alexander Kiselyov, Adrian Kotey, Thomas Krulle, John E. Mangette, Richard W. Marston, Sergio Menta, Matthew R. Mills, Edith Monteagudo, Sangram Nag, Martina Nibbio, Laura Orsatti, Sabine Schaertl, Christoph Scheich, Joanne Sproston, Vladimir Stepanov, Marie Svedberg, Akihiro Takano, Malcolm Taylor, Wayne Thomas, Miklós Toth, Darshan Vaidya, Katarina Vanräs, Derek Weddell, Ian Wigginton, John Wityak, Ladislav Mrzljak, Ignacio Munoz-Sanjuan, Jonathan A. Bard, Celia Dominguez. Imaging Mutant Huntingtin Aggregates: Development of a Potential PET Ligand. Journal of Medicinal Chemistry 2020, 63 (15) , 8608-8633. https://doi.org/10.1021/acs.jmedchem.0c00955
    29. Yuichi Wakabayashi, Sanjay Telu, Rachel M. Dick, Masahiro Fujita, Maarten Ooms, Cheryl L. Morse, Jeih-San Liow, Jinsoo S. Hong, Robert L. Gladding, Lester S. Manly, Sami S. Zoghbi, Xuesheng Mo, Emily C. D’Amato, Janice A. Sindac, Richard A. Nugent, Brian E. Marron, Mark E. Gurney, Robert B. Innis, Victor W. Pike. Discovery, Radiolabeling, and Evaluation of Subtype-Selective Inhibitors for Positron Emission Tomography Imaging of Brain Phosphodiesterase-4D. ACS Chemical Neuroscience 2020, 11 (9) , 1311-1323. https://doi.org/10.1021/acschemneuro.0c00077
    30. Ling Tong, Wenping Li, Michael Man-Chu Lo, Xiaolei Gao, Jenny Miu-Chen Wai, Michael Rudd, David Tellers, Aniket Joshi, Zhizhen Zeng, Patricia Miller, Cristian Salinas, Kerry Riffel, Hyking Haley, Mona Purcell, Marie Holahan, Liza Gantert, Jeffrey W. Schubert, Kristen Jones, James Mulhearn, Melissa Egbertson, Zhaoyang Meng, Barbara Hanney, Robert Gomez, Scott T. Harrison, Paul McQuade, Tjerk Bueters, Jason Uslaner, John Morrow, Fiona Thomson, Jongrock Kong, Jing Liao, Oleg Selyutin, Jianming Bao, Nicholas B. Hastings, Sony Agrawal, Brian C. Magliaro, Frederick J. Monsma, Jr., Michelle D. Smith, Stefania Risso, David Hesk, Eric Hostetler, Robert Mazzola. Discovery of [11C]MK-6884: A Positron Emission Tomography (PET) Imaging Agent for the Study of M4Muscarinic Receptor Positive Allosteric Modulators (PAMs) in Neurodegenerative Diseases. Journal of Medicinal Chemistry 2020, 63 (5) , 2411-2425. https://doi.org/10.1021/acs.jmedchem.9b01406
    31. Takeshi Fuchigami, Masao Kawasaki, Ryusuke Koyama, Mari Nakaie, Takehiro Nakagaki, Kazunori Sano, Ryuichiro Atarashi, Sakura Yoshida, Mamoru Haratake, Masahiro Ono, Noriyuki Nishida, Morio Nakayama. Development of Radioiodinated Benzofuran Derivatives for in Vivo Imaging of Prion Deposits in the Brain. ACS Infectious Diseases 2019, 5 (12) , 2003-2013. https://doi.org/10.1021/acsinfecdis.8b00184
    32. Vadim Bernard-Gauthier, Andrew V. Mossine, Ashley Knight, Debasis Patnaik, Wen-Ning Zhao, Chialin Cheng, Hema S. Krishnan, Lucius L. Xuan, Peter S. Chindavong, Surya A. Reis, Jinshan Michael Chen, Xia Shao, Jenelle Stauff, Janna Arteaga, Phillip Sherman, Nicolas Salem, David Bonsall, Brenda Amaral, Cassis Varlow, Lisa Wells, Laurent Martarello, Shil Patel, Steven H. Liang, Ravi G. Kurumbail, Stephen J. Haggarty, Peter J. H. Scott, Neil Vasdev. Structural Basis for Achieving GSK-3β Inhibition with High Potency, Selectivity, and Brain Exposure for Positron Emission Tomography Imaging and Drug Discovery. Journal of Medicinal Chemistry 2019, 62 (21) , 9600-9617. https://doi.org/10.1021/acs.jmedchem.9b01030
    33. Lei Zhang, Christopher R. Butler, Kevin P. Maresca, Akihiro Takano, Sangram Nag, Zhisheng Jia, Ryosuke Arakawa, Justin R. Piro, Tarek Samad, Deborah L. Smith, Deane M. Nason, Steven O’Neil, Laura McAllister, Klaas Schildknegt, Patrick Trapa, Timothy J. McCarthy, Anabella Villalobos, Christer Halldin. Identification and Development of an Irreversible Monoacylglycerol Lipase (MAGL) Positron Emission Tomography (PET) Radioligand with High Specificity. Journal of Medicinal Chemistry 2019, 62 (18) , 8532-8543. https://doi.org/10.1021/acs.jmedchem.9b00847
    34. Elina Tampio L’Estrade, Mengfei Xiong, Vladimir Shalgunov, Fraser G. Edgar, Balázs Volk, Simone L. Baerentzen, Mikael Palner, Maria Erlandsson, Tomas Ohlsson, Gitte M. Knudsen, Matthias M. Herth. Development and Evaluation of Two Potential 5-HT7 Receptor PET Tracers: [18F]ENL09 and [18F]ENL10. ACS Chemical Neuroscience 2019, 10 (9) , 3961-3968. https://doi.org/10.1021/acschemneuro.9b00132
    35. Hualong Fu, Weiting Tang, Zhen Chen, Vasily V. Belov, Genwei Zhang, Tuo Shao, Xiaofei Zhang, Qingzhen Yu, Jian Rong, Xiaoyun Deng, Wei Han, Scott J. Myers, Pilar Giffenig, Lu Wang, Lee Josephson, Yihan Shao, April T. Davenport, James B. Daunais, Mikhail Papisov, Hongjie Yuan, Zijing Li, Stephen F. Traynelis, Steven H. Liang. Synthesis and Preliminary Evaluations of a Triazole-Cored Antagonist as a PET Imaging Probe ([18F]N2B-0518) for GluN2B Subunit in the Brain. ACS Chemical Neuroscience 2019, 10 (5) , 2263-2275. https://doi.org/10.1021/acschemneuro.8b00591
    36. Ethan L. Fisher, Christopher W. am Ende, John M. Humphrey. 2,2,2-Trifluoroethoxy Aromatic Heterocycles: Hydrolytically Stable Alternatives to Heteroaryl Chlorides. The Journal of Organic Chemistry 2019, 84 (8) , 4904-4909. https://doi.org/10.1021/acs.joc.8b02453
    37. Zhen Chen, Wakana Mori, Xiaoyun Deng, Ran Cheng, Daisuke Ogasawara, Genwei Zhang, Michael A. Schafroth, Kenneth Dahl, Hualong Fu, Akiko Hatori, Tuo Shao, Yiding Zhang, Tomoteru Yamasaki, Xiaofei Zhang, Jian Rong, Qingzhen Yu, Kuan Hu, Masayuki Fujinaga, Lin Xie, Katsushi Kumata, Yuancheng Gou, Jingjin Chen, Shuyin Gu, Liang Bao, Lu Wang, Thomas Lee Collier, Neil Vasdev, Yihan Shao, Jun-An Ma, Benjamin F. Cravatt, Christopher Fowler, Lee Josephson, Ming-Rong Zhang, Steven H. Liang. Design, Synthesis, and Evaluation of Reversible and Irreversible Monoacylglycerol Lipase Positron Emission Tomography (PET) Tracers Using a “Tail Switching” Strategy on a Piperazinyl Azetidine Skeleton. Journal of Medicinal Chemistry 2019, 62 (7) , 3336-3353. https://doi.org/10.1021/acs.jmedchem.8b01778
    38. Yasushi Hattori, Kazunobu Aoyama, Jun Maeda, Naoto Arimura, Yasuko Takahashi, Masako Sasaki, Masayuki Fujinaga, Chie Seki, Yuji Nagai, Kazunori Kawamura, Tomoteru Yamasaki, Ming-Rong Zhang, Makoto Higuchi, Tatsuki Koike. Design, Synthesis, and Evaluation of (4R)-1-{3-[2-(18F)Fluoro-4-methylpyridin-3-yl]phenyl}-4-[4-(1,3-thiazol-2-ylcarbonyl)piperazin-1-yl]pyrrolidin-2-one ([18F]T-401) as a Novel Positron-Emission Tomography Imaging Agent for Monoacylglycerol Lipase. Journal of Medicinal Chemistry 2019, 62 (5) , 2362-2375. https://doi.org/10.1021/acs.jmedchem.8b01576
    39. Aleksandra Pekošak, Janez Ž. Bulc, Špela Korat, Robert C. Schuit, Esther Kooijman, Ricardo Vos, Marissa Rongen, Mariska Verlaan, Kevin Takkenkamp, Wissam Beaino, Alex J. Poot, Albert D. Windhorst. Synthesis and Preclinical Evaluation of the First Carbon-11 Labeled PET Tracers Targeting Substance P1–7. Molecular Pharmaceutics 2018, 15 (11) , 4872-4883. https://doi.org/10.1021/acs.molpharmaceut.8b00518
    40. Lei Zhang, Laigao Chen, Jason K. Dutra, Elizabeth M. Beck, Sangram Nag, Akihiro Takano, Nahid Amini, Ryosuke Arakawa, Michael A. Brodney, Leanne M. Buzon, Shawn D. Doran, Lorraine F. Lanyon, Timothy J. McCarthy, Kelly R. Bales, Charles E. Nolan, Brian T. O’Neill, Klaas Schildknegt, Christer Halldin, Anabella Villalobos. Identification of a Novel Positron Emission Tomography (PET) Ligand for Imaging β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE-1) in Brain. Journal of Medicinal Chemistry 2018, 61 (8) , 3296-3308. https://doi.org/10.1021/acs.jmedchem.7b01769
    41. Salvatore Bongarzone, Antony D. Gee. BACE1: Now We Can See You. Journal of Medicinal Chemistry 2018, 61 (8) , 3293-3295. https://doi.org/10.1021/acs.jmedchem.8b00474
    42. Lei Zhang, Laigao Chen, Elizabeth M. Beck, Thomas A. Chappie, Richard V. Coelho, Shawn D. Doran, Kuo-Hsien Fan, Christopher J. Helal, John M. Humphrey, Zoe Hughes, Kyle Kuszpit, Erik A. Lachapelle, John T. Lazzaro, Chewah Lee, Robert J. Mather, Nandini C. Patel, Marc B. Skaddan, Simone Sciabola, Patrick R. Verhoest, Joseph M. Young, Kenneth Zasadny, and Anabella Villalobos . The Discovery of a Novel Phosphodiesterase (PDE) 4B-Preferring Radioligand for Positron Emission Tomography (PET) Imaging. Journal of Medicinal Chemistry 2017, 60 (20) , 8538-8551. https://doi.org/10.1021/acs.jmedchem.7b01050
    43. Travis T. Wager, Paul Galatsis, Ramalakshmi Y. Chandrasekaran, Todd W. Butler, Jianke Li, Lei Zhang, Scot Mente, Chakrapani Subramanyam, Shenping Liu, Angela C. Doran, Cheng Chang, Katherine Fisher, Sarah Grimwood, Joseph R. Hedde, Michael Marconi, and Klaas Schildknegt . Identification and Profiling of a Selective and Brain Penetrant Radioligand for in Vivo Target Occupancy Measurement of Casein Kinase 1 (CK1) Inhibitors. ACS Chemical Neuroscience 2017, 8 (9) , 1995-2004. https://doi.org/10.1021/acschemneuro.7b00155
    44. Luca C. Gobbi, Henner Knust, Matthias Körner, Michael Honer, Christian Czech, Sara Belli, Dieter Muri, Martin R. Edelmann, Thomas Hartung, Isabella Erbsmehl, Sandra Grall-Ulsemer, Andreas Koblet, Marianne Rueher, Sandra Steiner, Hayden T. Ravert, William B. Mathews, Daniel P. Holt, Hiroto Kuwabara, Heather Valentine, Robert F. Dannals, Dean F. Wong, and Edilio Borroni . Identification of Three Novel Radiotracers for Imaging Aggregated Tau in Alzheimer’s Disease with Positron Emission Tomography. Journal of Medicinal Chemistry 2017, 60 (17) , 7350-7370. https://doi.org/10.1021/acs.jmedchem.7b00632
    45. Vadim Bernard-Gauthier, Justin J. Bailey, Andrew V. Mossine, Simon Lindner, Lena Vomacka, Arturo Aliaga, Xia Shao, Carole A. Quesada, Phillip Sherman, Anne Mahringer, Alexey Kostikov, Marilyn Grand’Maison, Pedro Rosa-Neto, Jean-Paul Soucy, Alexander Thiel, David R. Kaplan, Gert Fricker, Björn Wängler, Peter Bartenstein, Ralf Schirrmacher, and Peter J. H. Scott . A Kinome-Wide Selective Radiolabeled TrkB/C Inhibitor for in Vitro and in Vivo Neuroimaging: Synthesis, Preclinical Evaluation, and First-in-Human. Journal of Medicinal Chemistry 2017, 60 (16) , 6897-6910. https://doi.org/10.1021/acs.jmedchem.7b00396
    46. Christopher J. Helal, Eric P. Arnold, Tracey L. Boyden, Cheng Chang, Thomas A. Chappie, Kimberly F. Fennell, Michael D. Forman, Mihaly Hajos, John F. Harms, William E. Hoffman, John M. Humphrey, Zhijun Kang, Robin J. Kleiman, Bethany L. Kormos, Che-Wah Lee, Jiemin Lu, Noha Maklad, Laura McDowell, Scot Mente, Rebecca E. O’Connor, Jayvardhan Pandit, Mary Piotrowski, Anne W. Schmidt, Christopher J. Schmidt, Hirokazu Ueno, Patrick R. Verhoest, and Edward X. Yang . Application of Structure-Based Design and Parallel Chemistry to Identify a Potent, Selective, and Brain Penetrant Phosphodiesterase 2A Inhibitor. Journal of Medicinal Chemistry 2017, 60 (13) , 5673-5698. https://doi.org/10.1021/acs.jmedchem.7b00397
    47. Guy A. Higgins . 18F-FPP: A PET Ligand for the 5-HT2C Receptor?. ACS Chemical Neuroscience 2017, 8 (5) , 904-907. https://doi.org/10.1021/acschemneuro.7b00133
    48. David J. Cummins and Michael A. Bell . Integrating Everything: The Molecule Selection Toolkit, a System for Compound Prioritization in Drug Discovery. Journal of Medicinal Chemistry 2016, 59 (15) , 6999-7010. https://doi.org/10.1021/acs.jmedchem.5b01338
    49. Norihito Oi, Masaki Tokunaga, Michiyuki Suzuki, Yuji Nagai, Yosuke Nakatani, Noboru Yamamoto, Jun Maeda, Takafumi Minamimoto, Ming-Rong Zhang, Tetsuya Suhara, and Makoto Higuchi . Development of Novel PET Probes for Central 2-Amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic Acid Receptors. Journal of Medicinal Chemistry 2015, 58 (21) , 8444-8462. https://doi.org/10.1021/acs.jmedchem.5b00712
    50. Manuela Ariza, Hartmuth C. Kolb, Dieder Moechars, Frederik Rombouts, and José Ignacio Andrés . Tau Positron Emission Tomography (PET) Imaging: Past, Present, and Future. Journal of Medicinal Chemistry 2015, 58 (11) , 4365-4382. https://doi.org/10.1021/jm5017544
    51. Vadim Bernard-Gauthier, Arturo Aliaga, Antonio Aliaga, Mehdi Boudjemeline, Robert Hopewell, Alexey Kostikov, Pedro Rosa-Neto, Alexander Thiel, and Ralf Schirrmacher . Syntheses and Evaluation of Carbon-11- and Fluorine-18-Radiolabeled pan-Tropomyosin Receptor Kinase (Trk) Inhibitors: Exploration of the 4-Aza-2-oxindole Scaffold as Trk PET Imaging Agents. ACS Chemical Neuroscience 2015, 6 (2) , 260-276. https://doi.org/10.1021/cn500193f
    52. Vanessa Barth and Anne Need . Identifying Novel Radiotracers for PET Imaging of the Brain: Application of LC-MS/MS to Tracer Identification. ACS Chemical Neuroscience 2014, 5 (12) , 1148-1153. https://doi.org/10.1021/cn500072r
    53. Elizabeth M. Joshi, Anne Need, John Schaus, Zhaogen Chen, Dana Benesh, Charles Mitch, Stuart Morton, Thomas J. Raub, Lee Phebus, and Vanessa Barth . Efficiency Gains in Tracer Identification for Nuclear Imaging: Can In Vivo LC-MS/MS Evaluation of Small Molecules Screen for Successful PET Tracers?. ACS Chemical Neuroscience 2014, 5 (12) , 1154-1163. https://doi.org/10.1021/cn500073j
    54. Markus Piel, Ingo Vernaleken, and Frank Rösch . Positron Emission Tomography in CNS Drug Discovery and Drug Monitoring. Journal of Medicinal Chemistry 2014, 57 (22) , 9232-9258. https://doi.org/10.1021/jm5001858
    55. Genevieve C. Van de Bittner, Emily L. Ricq, and Jacob M. Hooker . A Philosophy for CNS Radiotracer Design. Accounts of Chemical Research 2014, 47 (10) , 3127-3134. https://doi.org/10.1021/ar500233s
    56. Yongjun Gao, Kenneth J. Kellar, Robert P. Yasuda, Thao Tran, Yingxian Xiao, Robert F. Dannals, and Andrew G. Horti . Derivatives of Dibenzothiophene for Positron Emission Tomography Imaging of α7-Nicotinic Acetylcholine Receptors. Journal of Medicinal Chemistry 2013, 56 (19) , 7574-7589. https://doi.org/10.1021/jm401184f
    57. Wissam Beaino, Esther JM Kooijman, Eryn L. Werry, Rens J. Vellinga, Johan Van den Hoek, Greta Sohler, Grace A. Cumbers, Elijah Genetzakis, Edward D. Harvey-Latham, Robert C. Schuit, Michael Kassiou, Albert D. Windhorst, Jonathan J. Danon. Development and evaluation of [11C]DPA-813 and [18F]DPA-814: novel TSPO PET tracers insensitive to human single nucleotide polymorphism rs6971. European Journal of Nuclear Medicine and Molecular Imaging 2025, 53 https://doi.org/10.1007/s00259-025-07109-1
    58. Bote Qi, Lulu Guan, Jingwang Tan, Gengchen Li, Yunxiang Sun, Qingwen Zhang, Yu Zou. Identification of novel tau positron emission tomography tracers for chronic traumatic encephalopathy by comprehensive in silico screening and molecular dynamics simulation. Physical Chemistry Chemical Physics 2025, 27 (2) , 754-767. https://doi.org/10.1039/D4CP03207A
    59. Luyang Shi, Xue Wang, Hongzong Si, Wangdi Song. PDE4D inhibitors: Opening a new era of PET diagnostics for Alzheimer's disease. Neurochemistry International 2025, 182 , 105903. https://doi.org/10.1016/j.neuint.2024.105903
    60. Anton Lindberg, Emily Murrell, Junchao Tong, N. Scott Mason, Daniel Sohn, Johan Sandell, Peter Ström, Jeffrey S. Stehouwer, Brian J. Lopresti, Jenny Viklund, Samuel Svensson, Chester A. Mathis, Neil Vasdev. Ligand-based design of [18F]OXD-2314 for PET imaging in non-Alzheimer’s disease tauopathies. Nature Communications 2024, 15 (1) https://doi.org/10.1038/s41467-024-49258-1
    61. Elisabet Jakova, Omozojie P. Aigbogun, Mohamed Taha Moutaoufik, Kevin J. H. Allen, Omer Munir, Devin Brown, Changiz Taghibiglou, Mohan Babu, Chris P. Phenix, Ed S. Krol, Francisco S. Cayabyab. The Bifunctional Dimer Caffeine-Indan Attenuates α-Synuclein Misfolding, Neurodegeneration and Behavioral Deficits after Chronic Stimulation of Adenosine A1 Receptors. International Journal of Molecular Sciences 2024, 25 (17) , 9386. https://doi.org/10.3390/ijms25179386
    62. Lian Xue, Caitlin V. M. L. Jie, Sandrine Desrayaud, Yves P. Auberson. Developing Low Molecular Weight PET and SPECT Imaging Agents. ChemMedChem 2024, 19 (15) https://doi.org/10.1002/cmdc.202400094
    63. Katharina Distler, Simone Maschauer, Eduard Neu, Harald Hübner, Jürgen Einsiedel, Olaf Prante, Peter Gmeiner. Structure-guided discovery of orexin receptor-binding PET ligands. Bioorganic & Medicinal Chemistry 2024, 110 , 117823. https://doi.org/10.1016/j.bmc.2024.117823
    64. Bing Li, Palak Wadhwa, Walter Lerchner, Paolo Zanotti-Fregonara, Jeih-San Liow, Xuefeng Yan, Sami S. Zoghbi, Sridhar Goud Nerella, Sanjay Telu, Cheryl L. Morse, Oscar Solis, Juan L. Gomez, Daniel P. Holt, Robert F. Dannals, Alex C. Cummins, Robert B. Innis, Victor W. Pike, Barry J. Richmond, Michael Michaelides, Mark A.G. Eldridge. Evaluation of [18F]fluoroestradiol and ChRERα as a gene expression PET reporter system in rhesus monkey brain. Molecular Therapy 2024, 32 (7) , 2223-2231. https://doi.org/10.1016/j.ymthe.2024.05.031
    65. Meijuan Jiang, Shiyu Tang, Madeline D. Jenkins, Adrian C. Lee, Bruny Kenou, Carson Knoer, Jose Montero Santamaria, Shawn Wu, Jeih-San Liow, Sami S. Zoghbi, Paolo Zanotti-Fregonara, Robert B. Innis, Sanjay Telu, Victor W. Pike. Robust Quantification of Phosphodiesterase-4D in Monkey Brain with PET and 11 C-Labeled Radioligands That Avoid Radiometabolite Contamination. Journal of Nuclear Medicine 2024, 65 (5) , 788-793. https://doi.org/10.2967/jnumed.123.266750
    66. Yingfang He, Aro Delparente, Caitlin V. M. L Jie, Claudia Keller, Roland Humm, Dominik Heer, Ludovic Collin, Roger Schibli, Luca Gobbi, Uwe Grether, Linjing Mu. Preclinical Evaluation of the Reversible Monoacylglycerol Lipase PET Tracer ( R )‐[ 11 C]YH132: Application in Drug Development and Neurodegenerative Diseases. ChemBioChem 2024, 25 (7) https://doi.org/10.1002/cbic.202300819
    67. Haruka Saito, Hiroyuki Watanabe, Masahiro Ono. Synthesis and biological evaluation of novel 18F-labeled 2,4-diaminopyrimidine derivatives for detection of ghrelin receptor in the brain. Bioorganic & Medicinal Chemistry Letters 2024, 99 , 129625. https://doi.org/10.1016/j.bmcl.2024.129625
    68. Volker Derdau, Charles S. Elmore, Thomas Hartung, Bruce McKillican, Tom Mejuch, Claudia Rosenbaum, Christine Wiebe. Die Zukunft (Radio‐)‐isotopenmarkierter Verbindungen in Forschung und Entwicklung der modernen Lebenswissenschaften. Angewandte Chemie 2023, 135 (52) https://doi.org/10.1002/ange.202306019
    69. Volker Derdau, Charles S. Elmore, Thomas Hartung, Bruce McKillican, Tom Mejuch, Claudia Rosenbaum, Christine Wiebe. The Future of (Radio)‐Labeled Compounds in Research and Development within the Life Science Industry. Angewandte Chemie International Edition 2023, 62 (52) https://doi.org/10.1002/anie.202306019
    70. Hiroshi Ikenuma, Aya Ogata, Hiroko Koyama, Bin Ji, Hideki Ishii, Takashi Yamada, Junichiro Abe, Chie Seki, Yuji Nagai, Masanori Ichise, Takafumi Minamimoto, Makoto Higuchi, Ming-Rong Zhang, Takashi Kato, Kengo Ito, Masaaki Suzuki, Yasuyuki Kimura. Synthesis and evaluation of a novel PET ligand, a GSK’963 analog, aiming at autoradiography and imaging of the receptor interacting protein kinase 1 in the brain. EJNMMI Radiopharmacy and Chemistry 2023, 8 (1) https://doi.org/10.1186/s41181-023-00217-z
    71. Neil Vasdev, Anton Lindberg, Junchao Tong, Scott Mason, Daniel Sohn, Johan Sandell, Peter Strom, Jeffrey Stehouwer, Brian Lopresti, Jenny Viklund, Samuel Svensson, Chester Mathis. Structure-guided design of pyridinyl-indole 4R-tau PET radiotracers: Development of [18F]OXD-2314 for human use. 2023https://doi.org/10.21203/rs.3.rs-3182844/v1
    72. Jan Marik, Sharyl Rich, Gauri Deshmukh, Donglu Zhang, Jeff Tinianow, Jingwei Cai, Susan Wong, Sudheer Bobba, Kevin DeMent, Ning Liu, Jason Halladay, Sandra Sanabria-Bohórquez, Lionel Cheruzel, Cyrus Khojasteh. GTP1 metabolic stability assessment: A study of the tau PET tracer [18F]GTP1. Nuclear Medicine and Biology 2023, 124-125 , 108386. https://doi.org/10.1016/j.nucmedbio.2023.108386
    73. Romy Cools, Kobe Kerkhofs, Renan C.F. Leitao, Guy Bormans. Preclinical Evaluation of Novel PET Probes for Dementia. Seminars in Nuclear Medicine 2023, 53 (5) , 599-629. https://doi.org/10.1053/j.semnuclmed.2023.03.004
    74. Anton Lindberg, Melissa Chassé, Cassis Varlow, Anna Pees, Neil Vasdev. Strategies for designing novel positron emission tomography (PET) radiotracers to cross the blood–brain barrier. Journal of Labelled Compounds and Radiopharmaceuticals 2023, 66 (9) , 205-221. https://doi.org/10.1002/jlcr.4019
    75. Michael Honer, Alessandra Polara, Hiroto Kuwabara, Helmut Jacobsen, Axel Pähler, Thomas Hartung, Antonello Caruso, Daria Esterhazy, Markus Stoffel, Robert F. Dannals, Dean F. Wong, Edilio Borroni, Luca C. Gobbi. RO6807936 as a novel positron emission tomography (PET) radiotracer for in vitro and in vivo visualization and quantification of beta‐site amyloid precursor protein cleaving enzyme (BACE1) in the rodent and baboon brain. Journal of Labelled Compounds and Radiopharmaceuticals 2023, 66 (9) , 222-236. https://doi.org/10.1002/jlcr.4025
    76. Yanbo Yu, Hao Jiang, Qianwa Liang, Lin Qiu, Tianyu Huang, Hongzhen Hu, Vadim Y. Bolshakov, Joel S. Perlmutter, Zhude Tu. Radiosynthesis and Evaluation of a C-11 Radiotracer for Transient Receptor Potential Canonical 5 in the Brain. Molecular Imaging and Biology 2023, 25 (2) , 334-342. https://doi.org/10.1007/s11307-022-01760-y
    77. Felix Neumaier, Boris D. Zlatopolskiy, Bernd Neumaier. Mutated Isocitrate Dehydrogenase (mIDH) as Target for PET Imaging in Gliomas. Molecules 2023, 28 (7) , 2890. https://doi.org/10.3390/molecules28072890
    78. Ni Zhang, Fei Pan, Lili Pan, Wei Diao, Feijing Su, Rui Huang, Bo Yang, Yunchun Li, Zhongzhi Qi, Wenjie Zhang, Xiaoai Wu. Synthesis, radiolabeling, and evaluation of a (4-quinolinoyl)glycyl-2-cyanopyrrolidine analogue for fibroblast activation protein (FAP) PET imaging. Frontiers in Bioengineering and Biotechnology 2023, 11 https://doi.org/10.3389/fbioe.2023.1167329
    79. Chia-Ju Hsieh, Sam Giannakoulias, E. James Petersson, Robert H. Mach. Computational Chemistry for the Identification of Lead Compounds for Radiotracer Development. Pharmaceuticals 2023, 16 (2) , 317. https://doi.org/10.3390/ph16020317
    80. Yingfang He, Uwe Grether, Marco F. Taddio, Carla Meier, Claudia Keller, Martin R. Edelmann, Michael Honer, Sylwia Huber, Matthias B. Wittwer, Dominik Heer, Hans Richter, Ludovic Collin, Melanie N. Hug, Manuel Hilbert, Annemarieke G.J. Postmus, Anna Floor Stevens, Mario van der Stelt, Stefanie D. Krämer, Roger Schibli, Linjing Mu, Luca C. Gobbi. Multi-parameter optimization: Development of a morpholin-3-one derivative with an improved kinetic profile for imaging monoacylglycerol lipase in the brain. European Journal of Medicinal Chemistry 2022, 243 , 114750. https://doi.org/10.1016/j.ejmech.2022.114750
    81. Yves P. Auberson, Akané Lièvre, Sandrine Desrayaud, Emmanuelle Briard. A practical approach to the optimization of positron emission tomography imaging agents for the central nervous system. Journal of Labelled Compounds and Radiopharmaceuticals 2022, 65 (13) , 343-350. https://doi.org/10.1002/jlcr.4004
    82. Tatsuki Koike. Development of Specific PET Tracers for Central Nervous System Drug Targets. Journal of Synthetic Organic Chemistry, Japan 2022, 80 (11) , 1044-1054. https://doi.org/10.5059/yukigoseikyokaishi.80.1044
    83. Shuhei Ikeda, Yuichi Kajita, Maki Miyamoto, Kouta Matsumiya, Tsuyoshi Ishii, Toshiya Nishi, Sean C. Gay, Weston Lane, Cristian C. Constantinescu, David Alagille, Caroline Papin, Gilles Tamagnan, Takanobu Kuroita, Tatsuki Koike. Design and synthesis of aryl-piperidine derivatives as potent and selective PET tracers for cholesterol 24-hydroxylase (CH24H). European Journal of Medicinal Chemistry 2022, 240 , 114612. https://doi.org/10.1016/j.ejmech.2022.114612
    84. Ben B. Ma, Andrew P. Montgomery, Biling Chen, Michael Kassiou, Jonathan J. Danon. Strategies for targeting the P2Y12 receptor in the central nervous system. Bioorganic & Medicinal Chemistry Letters 2022, 71 , 128837. https://doi.org/10.1016/j.bmcl.2022.128837
    85. Monica Viviano, Elisabetta Barresi, Fabrice G. Siméon, Barbara Costa, Sabrina Taliani, Federico Da Settimo, Victor W. Pike, Sabrina Castellano. Essential Principles and Recent Progress in the Development of TSPO PET Ligands for Neuroinflammation Imaging. Current Medicinal Chemistry 2022, 29 (28) , 4862-4890. https://doi.org/10.2174/0929867329666220329204054
    86. Tianxin Gao, Pei Wang, Teng Gong, Ying Zhou, Ancong Wang, Xiaoying Tang, Xiaolei Song, Yingwei Fan. Reporter Genes for Brain Imaging Using MRI, SPECT and PET. International Journal of Molecular Sciences 2022, 23 (15) , 8443. https://doi.org/10.3390/ijms23158443
    87. Yingfang He, Luca C. Gobbi, Adrienne Müller Herde, Didier Rombach, Martin Ritter, Bernd Kuhn, Matthias B. Wittwer, Dominik Heer, Benoit Hornsperger, Charles Bell, Fionn O'Hara, Jörg Benz, Michael Honer, Claudia Keller, Ludovic Collin, Hans Richter, Roger Schibli, Uwe Grether, Linjing Mu. Discovery, synthesis and evaluation of novel reversible monoacylglycerol lipase radioligands bearing a morpholine-3-one scaffold. Nuclear Medicine and Biology 2022, 108-109 , 24-32. https://doi.org/10.1016/j.nucmedbio.2022.02.002
    88. Lili Pan, Qian He, Yi Wu, Ni Zhang, Huawei Cai, Bo Yang, Yuxi Wang, Yunchun Li, Xiaoai Wu. Synthesis, radiolabeling, and evaluation of a potent β-site APP cleaving enzyme (BACE1) inhibitor for PET imaging of BACE1 in vivo. Bioorganic & Medicinal Chemistry Letters 2022, 59 , 128543. https://doi.org/10.1016/j.bmcl.2022.128543
    89. Mari Nakaie, Fumihiro Katayama, Takehiro Nakagaki, Masao Kawasaki, Sakura Yoshida, Akira Toriba, Kazuma Ogawa, Noriyuki Nishida, Morio Nakayama, Takeshi Fuchigami. Synthesis and Characterization of Hydroxyethylamino- and Pyridyl-Substituted 2-Vinyl Chromone Derivatives for Detection of Cerebral Abnormal Prion Protein Deposits. Chemical and Pharmaceutical Bulletin 2022, 70 (3) , 211-219. https://doi.org/10.1248/cpb.c21-00902
    90. Stina Syvänen, Roger N. Gunn, Lei Zhang. Principles of PET and Its Role in Understanding Drug Delivery to the Brain. 2022, 329-352. https://doi.org/10.1007/978-3-030-88773-5_11
    91. Shuhei Ikeda, Yuichi Kajita, Maki Miyamoto, Kouta Matsumiya, Tsuyoshi Ishii, Toshiya Nishi, Sean C. Gay, Weston Lane, Cristian C. Constantinescu, David Alagille, Caroline Papin, Gilles Tamagnan, Takanobu Kuroita, Tatsuki Koike. Design and Synthesis of Aryl-Piperidine Derivatives as Potent and Selective PET Tracers for Cholesterol 24-Hydroxylase (CH24H). SSRN Electronic Journal 2022, 78 https://doi.org/10.2139/ssrn.4137501
    92. Bahar Ataeinia, Pedram Heidari. Artificial Intelligence and the Future of Diagnostic and Therapeutic Radiopharmaceutical Development. PET Clinics 2021, 16 (4) , 513-523. https://doi.org/10.1016/j.cpet.2021.06.008
    93. Felix Neumaier, Boris D. Zlatopolskiy, Bernd Neumaier. Drug Penetration into the Central Nervous System: Pharmacokinetic Concepts and In Vitro Model Systems. Pharmaceutics 2021, 13 (10) , 1542. https://doi.org/10.3390/pharmaceutics13101542
    94. Olivier Barret, Lei Zhang, David Alagille, Cristian C. Constantinescu, Christine Sandiego, Caroline Papin, Jenna M. Sullivan, Thomas Morley, Vincent M. Carroll, John Seibyl, Jianqing Chen, Chewah Lee, Anabella Villalobos, David Gray, Timothy J. McCarthy, Gilles Tamagnan. Dopamine D 1 Receptor Agonist PET Tracer Development: Assessment in Nonhuman Primates. Journal of Nuclear Medicine 2021, 62 (9) , 1307-1313. https://doi.org/10.2967/jnumed.120.256008
    95. Špela Korat, Natasha Shalina Rajani Bidesi, Federica Bonanno, Adriana Di Nanni, Anh Nguyên Nhât Hoàng, Kristina Herfert, Andreas Maurer, Umberto Maria Battisti, Gregory David Bowden, David Thonon, Daniëlle Vugts, Albert Dirk Windhorst, Matthias Manfred Herth. Alpha-Synuclein PET Tracer Development—An Overview about Current Efforts. Pharmaceuticals 2021, 14 (9) , 847. https://doi.org/10.3390/ph14090847
    96. Laura Kuebler, Sabrina Buss, Andrei Leonov, Sergey Ryazanov, Felix Schmidt, Andreas Maurer, Daniel Weckbecker, Anne M. Landau, Thea P. Lillethorup, Daniel Bleher, Ran Sing Saw, Bernd J. Pichler, Christian Griesinger, Armin Giese, Kristina Herfert. [11C]MODAG-001—towards a PET tracer targeting α-synuclein aggregates. European Journal of Nuclear Medicine and Molecular Imaging 2021, 48 (6) , 1759-1772. https://doi.org/10.1007/s00259-020-05133-x
    97. Susann Schröder, Matthias Scheunemann, Barbara Wenzel, Peter Brust. Challenges on Cyclic Nucleotide Phosphodiesterases Imaging with Positron Emission Tomography: Novel Radioligands and (Pre-)Clinical Insights since 2016. International Journal of Molecular Sciences 2021, 22 (8) , 3832. https://doi.org/10.3390/ijms22083832
    98. Linjing Mu, Simon M. Ametamey. Current Radioligands for the PET Imaging of Metabotropic Glutamate Receptors. 2021, 427-481. https://doi.org/10.1007/978-3-030-53176-8_13
    99. Takeshi Fuchigami, Morio Nakayama, Yasuhiro Magata. Development of PET and SPECT Radioligands for In Vivo Imaging of NMDA Receptors. 2021, 661-711. https://doi.org/10.1007/978-3-030-53176-8_19
    100. Ralf Schirrmacher, Vadim Bernard-Gauthier, Carolin Jaworski, Carmen Wängler, Björn Wängler, Justin Bailey. Toward Imaging Tropomyosin Receptor Kinase (Trk) with Positron Emission Tomography. 2021, 1041-1059. https://doi.org/10.1007/978-3-030-53176-8_31
    Load all citations

    Journal of Medicinal Chemistry

    Cite this: J. Med. Chem. 2013, 56, 11, 4568–4579
    Click to copy citationCitation copied!
    https://doi.org/10.1021/jm400312y
    Published May 7, 2013
    Copyright © 2013 American Chemical Society

    Article Views

    6019

    Altmetric

    -

    Citations

    Learn about these metrics

    Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.

    Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.

    The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated.